E&OE… Topics: Long-term national health plan; cystic fibrosis drug; Medicare; Cory Bernardi DAVID SPEERS: Minister for Health and Sport, Greg Hunt, who is with me now. Thank you very much for joining us and congratulations. GREG HUNT: And good afternoon to you. DAVID SPEERS: We haven’t spoken since your appointment in that role. Let me…
GREG HUNT: To Nettie and to everybody with Cystic Fibrosis Australia, thank you for having me here today and thank you for the fight and commitment that you’ve made to your family members and your friends. This is what life is about, and I’m really delighted to be here with Sarah Henderson, who as the…
From today, children aged two to five will have immediate and free access to Kalydeco® (ivacaftor) – a life-changing drug that addresses the causes of cystic fibrosis rather than just the symptoms. Previously, only children six years of age and older with the G551D or other class III gating mutations had subsidised access to Kalydeco.…
